Regulation and Prequalification

Publications

All →
Report of the 49th meeting of the WHO Global Advisory Committee on Vaccine Safety, 27-28 November 2025

The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 as an independent expert advisory body to WHO on policies and issues related...

WHO Drug Information - Volume 40, No. 1

The First issue of volume 40 for 2026 includes:Consultation Documents: - Dapsone (dapsonum)- Dapsone Tablets (dapsoni compressi)International Nonproprietary...

WHO Drug Information - Volume 39, No. 4

The Fourth issue of volume 39 for 2025 includes:Pharmaceutical News- Thin-Layer Chromatography: A Valuable Tool in the Fight Against Substandard/Falsified...

Advancing institutional compliance and continuous improvement in vaccine manufacturing: Virtual training marathon kit 2024

The 2024 Virtual cGMP Training Marathon represented a crucial step towards strengthening local vaccine manufacturing capabilities in LMICs. This annual...

Related documents

Cover image of the Call for action "Greener pharmaceuticals regulatory highway"
Call for action on regulatory support for introduction of more sustainable products and services

An effective regulatory system plays a critical role in ensuring the quality of health products, spanning from their development in the laboratory to their...

Newsletters

All →
WHO pharmaceuticals newsletter - No. 3, 2025

The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities...

WHO pharmaceuticals newsletter - No. 2, 2025

The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities...